These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37141541)

  • 21. How fast up the ladder? Factors associated with immunosuppressive or anti-TNF therapies in IBD patients at early stages: results from a population-based cohort.
    Ott C; Takses A; Obermeier F; Schnoy E; Salzberger B; Müller M
    Int J Colorectal Dis; 2014 Nov; 29(11):1329-38. PubMed ID: 25179426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Anti-tumour Necrosis Factor Agents on the Risk of Colorectal Cancer in Patients with Ulcerative Colitis: Nationwide French Cohort Study.
    Charkaoui M; Hajage D; Tubach F; Beaugerie L; Kirchgesner J
    J Crohns Colitis; 2022 Jul; 16(6):893-899. PubMed ID: 34657962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergency subtotal colectomy rates in relation to anti-TNF therapy in inflammatory bowel disease patients: comparison of retrospective cohorts.
    Sajjadi S; Svensson Neufert R; Ruhr E; Tryggmo S; Marsal J; Buchwald P
    Scand J Gastroenterol; 2023 Jan; 58(1):15-19. PubMed ID: 35917586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline risk assessment of patients with ulcerative colitis: does initial treatment selection influence outcomes?
    Mosli M; Alfaer S; Almalaki T; Albeshry A; Aljehani S; Alshmrani B; Habib Z; Jawa H; Qari Y
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):80-85. PubMed ID: 30199472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
    Charpentier C; Salleron J; Savoye G; Fumery M; Merle V; Laberenne JE; Vasseur F; Dupas JL; Cortot A; Dauchet L; Peyrin-Biroulet L; Lerebours E; Colombel JF; Gower-Rousseau C
    Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term course of ulcerative colitis in the prebiologic era. A retrospective study in a tertiary referral center.
    Margagnoni G; Fascì Spurio F; Feigusch L; Koch M; Papi C; Aratari A
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):275-83. PubMed ID: 25384806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study.
    Kaplan GG; Seow CH; Ghosh S; Molodecky N; Rezaie A; Moran GW; Proulx MC; Hubbard J; MacLean A; Buie D; Panaccione R
    Am J Gastroenterol; 2012 Dec; 107(12):1879-87. PubMed ID: 23165448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.
    Cañas-Ventura A; Márquez L; Ricart E; Domènech E; Gisbert JP; García-Sanchez V; Marín-Jiménez I; Rodriguez-Moranta F; Gomollón F; Calvet X; Merino O; Garcia-Planella E; Vázquez-Romero N; Esteve M; Iborra M; Gutiérrez A; Vera M; Andreu M;
    J Crohns Colitis; 2014 Oct; 8(10):1287-93. PubMed ID: 24726696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative outcome of colectomy for pediatric patients with ulcerative colitis.
    Patton D; Gupta N; Wojcicki JM; Garnett EA; Nobuhara K; Heyman MB
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):151-4. PubMed ID: 20410838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presenting features and disease course of pediatric ulcerative colitis.
    Aloi M; D'Arcangelo G; Pofi F; Vassallo F; Rizzo V; Nuti F; Di Nardo G; Pierdomenico M; Viola F; Cucchiara S
    J Crohns Colitis; 2013 Dec; 7(11):e509-15. PubMed ID: 23583691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis.
    Kevans D; Waterman M; Milgrom R; Xu W; Van Assche G; Silverberg M
    J Gastroenterol Hepatol; 2015 Jan; 30(1):64-70. PubMed ID: 25041458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends of Utilization of Tumor Necrosis Factor Antagonists in Children With Inflammatory Bowel Disease: A Canadian Population-Based Study.
    El-Matary W; Leung S; Tennakoon A; Benchimol EI; Bernstein CN; Targownik LE
    Inflamm Bowel Dis; 2020 Jan; 26(1):134-138. PubMed ID: 31323083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, Scotland.
    Jenkinson PW; Plevris N; Lyons M; Grant R; Fulforth J; Kirkwood K; Arnott ID; Wilson D; Watson AJM; Jones GR; Lees CW
    Colorectal Dis; 2021 May; 23(5):1175-1183. PubMed ID: 33350054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of anti-TNFα therapy on colectomy rates and corticosteroid treatment among 3001 paediatric and adolescent patients with ulcerative colitis-a nationwide study from 1995 to 2015.
    Lund K; Larsen MD; Knudsen T; Kjeldsen J; Nielsen RG; Nørgård BM
    Aliment Pharmacol Ther; 2019 Nov; 50(10):1077-1085. PubMed ID: 31579961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.
    Taxonera C; Iglesias E; Muñoz F; Calvo M; Barreiro-de Acosta M; Busquets D; Calvet X; Rodríguez A; Pajares R; Gisbert JP; López-Serrano P; Pérez-Calle JL; Ponferrada Á; De la Coba C; Bermejo F; Chaparro M; Olivares D; Alba C; Fernández-Blanco I
    Dig Dis Sci; 2017 Feb; 62(2):481-490. PubMed ID: 27995400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease Course and Colectomy Rate of Ulcerative Colitis: A Follow-up Cohort Study of a Referral Center in Tuscany.
    Manetti N; Bagnoli S; Rogai F; Bonanomi AG; Vannozzi G; Giannotta M; Annese V
    Inflamm Bowel Dis; 2016 Aug; 22(8):1945-53. PubMed ID: 27104823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colectomy rate in ulcerative colitis 15 years after diagnosis: Results from the 2001-2003 Navarra cohort.
    Rodríguez C; Elosua A; Prieto C; Pérez E; Irisarri R; Campillo A; Rubio S; Nantes Ó; Angós R; Zozaya JM
    Gastroenterol Hepatol; 2022 Jan; 45(1):1-8. PubMed ID: 33545242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study.
    Reich KM; Chang HJ; Rezaie A; Wang H; Goodman KJ; Kaplan GG; Svenson LW; Lees G; Fedorak RN; Kroeker KI
    Aliment Pharmacol Ther; 2014 Sep; 40(6):629-38. PubMed ID: 25039715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does anti-TNF therapy reduce the requirement for surgery in ulcerative colitis? A systematic review.
    Filippi J; Allen PB; Hébuterne X; Peyrin-Biroulet L
    Curr Drug Targets; 2011 Sep; 12(10):1440-7. PubMed ID: 21466486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study.
    Eriksson C; Rundquist S; Cao Y; Montgomery S; Halfvarson J
    Gut; 2019 Apr; 68(4):623-632. PubMed ID: 29618498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.